SCHEDULE 13G/A: AIGH Capital Management and Orin Hirschman Disclose Significant Stake in Personalis, Inc.

AIGH Capital Management LLC and Orin Hirschman have jointly filed an amended Schedule 13G, disclosing beneficial ownership of 6.1% and 5.4% respectively, in Personalis, Inc. common stock as of December 31, 2024.

Summary

• Orin Hirschman, along with AIGH Capital Management LLC and AIGH Investment Partners LLC, collectively referred to as the 'Reporting Persons,' have filed an Amendment No. 2 to Schedule 13G.
• The filing pertains to the beneficial ownership of Common Stock in Personalis, Inc. (CUSIP: 71535D106).
• As of December 31, 2024, Orin Hirschman beneficially owns 4,293,639 shares, representing 6.1% of the class.
• As of December 31, 2024, AIGH Capital Management LLC beneficially owns 3,799,064 shares, representing 5.4% of the class.
• Both Orin Hirschman and AIGH Capital Management LLC report sole voting and sole dispositive power over their respective shares.
• The shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing the control of Personalis, Inc.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that inherently indicates positive or negative sentiment regarding the company's performance or outlook.

Future Outlook

NA

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11."

Industry Context

This filing is a standard disclosure of beneficial ownership by an institutional investor, indicating a significant stake in a publicly traded company within the biotechnology or healthcare sector, specifically Personalis, Inc., which operates in genomics and precision medicine.

Stakeholder Impact

• Shareholders: Provides transparency regarding significant institutional ownership, which can influence market perception and trading activity.

Key Dates

Keywords

Personalis Inc., AIGH Capital Management, Orin Hirschman, Beneficial Ownership, Schedule 13G, SEC Filing, Common Stock, Investment Management